BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22008189)

  • 1. Time course and pattern of COPD exacerbation onset.
    Aaron SD; Donaldson GC; Whitmore GA; Hurst JR; Ramsay T; Wedzicha JA
    Thorax; 2012 Mar; 67(3):238-43. PubMed ID: 22008189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.
    Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA
    Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.
    Boer LM; Bischoff EW; Borgijink X; Vercoulen JH; Akkermans RP; Kerstjens HAM; Assendelft WJ; Schermer TR
    NPJ Prim Care Respir Med; 2018 Apr; 28(1):12. PubMed ID: 29615628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and characterization of COPD exacerbations using real-time data collection.
    Ejiofor SI; Stolk J; Fernandez P; Stockley RA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():427-434. PubMed ID: 28182151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
    Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
    Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program.
    Cushen B; McCormack N; Hennigan K; Sulaiman I; Costello RW; Deering B
    Respir Med; 2016 Oct; 119():55-62. PubMed ID: 27692148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
    Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission.
    Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of COPD Exacerbations and compliance with patient-reported daily symptom diaries using a smart phone-based information system [corrected].
    Johnston NW; Lambert K; Hussack P; de Verdier MG; Higenbottam T; Lewis J; Newbold P; Jenkins M; Norman GR; Coyle PV; McIvor RA
    Chest; 2013 Aug; 144(2):507-514. PubMed ID: 23519329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colds as predictors of the onset and severity of COPD exacerbations.
    Johnston NW; Olsson M; Edsbäcker S; Gerhardsson de Verdier M; Gustafson P; McCrae C; Coyle PV; McIvor RA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():839-848. PubMed ID: 28331305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
    Seemungal TA; Donaldson GC; Bhowmik A; Jeffries DJ; Wedzicha JA
    Am J Respir Crit Care Med; 2000 May; 161(5):1608-13. PubMed ID: 10806163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
    Watz H; Tetzlaff K; Magnussen H; Mueller A; Rodriguez-Roisin R; Wouters EFM; Vogelmeier C; Calverley PMA
    Respir Res; 2018 Dec; 19(1):251. PubMed ID: 30545350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation.
    Calverley PM; Page C; Dal Negro RW; Fontana G; Cazzola M; Cicero AF; Pozzi E; Wedzicha JA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2733-2744. PubMed ID: 31819405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease.
    Wilkinson TM; Donaldson GC; Hurst JR; Seemungal TA; Wedzicha JA
    Am J Respir Crit Care Med; 2004 Jun; 169(12):1298-303. PubMed ID: 14990395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
    Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
    Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.